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monary bypass and serious complications,
particularly when the nadir hematocrit de-
creased to less than 22%.
In these 3 studies, the age, weight, se-
riousness of the disease, previous cerebro-
vascular accident, duration of circulatory
arrest, and percentage of emergency sur-
gery were completely different. Therefore,
it might be very difficult to compare the
results and determine an appropriate he-
matocrit level during cardiopulmonary by-
pass, especially for surgical cases using
deep hypothermic circulatory arrest. Re-
garding the backgrounds of the patients,
our study group was considered to be the
best candidates for hemodilution during
cardiopulmonary bypass. Transfusion has
been proven to be an effective therapy for
hemodilutional anemia. However, this ther-
apy may cause severe adverse effects. Al-
though there were no adverse effects in our
study group, we agree with Dr Jonas that a
prospective randomized study should be
performed not only in adults, but also in
children with simple congenital heart de-
fects to determine the appropriate hemato-
crit level that improves a patient’s chance
for the most favorable outcome.
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Extrapleural pneumonectomy for
malignant mesothelioma: Should
pericardium be resected routinely?
To the Editor:
We read with interest the article by Sugar-
baker and colleagues1 in the July issue of
the Journal. This study reports their exten-
sive experience with the management of
complications occurring after extrapleural
pneumonectomy (EPP) done mainly for
malignant mesothelioma. It is clear from
the Sugarbaker article that technical com-
plications might arise from the resection
and replacement of the pericardium with a
patch, such as size mismatch, improper in-
sertion and suturing, or inadequate fenes-
tration. Three percent of their patients had
cardiac arrest, 2.7% had constrictive phys-
iology caused by inflammatory epicarditis,
3.6% had tamponade, and 44.2% had atrial
fibrillation.
Although we recognize the importance of
Sugarbaker’s work in studying specific com-
plications of EPP and reporting the largest
series to date, we would like to emphasize a
particular technical point that might prove
useful in some patients. Recently, we have
been surprised that some patients with stage I
or II malignant mesothelioma receiving in-
duction chemotherapy before EPP presented
at the operation with a pericardium macro-
scopically free of disease. In those patients
we have taken random biopsy specimens of
the pericardium and have preserved them.
Histopathology confirmed the absence of
pericardial invasion in all patients. In such
patients with a macroscopically normal peri-
cardium, we suggest taking frozen sections of
the pericardium and preserving them if the
frozen sections are negative. Although we do
agree that pericardium has to be resected in
most patients with malignant pleural me-
sothelioma, it is likely that with the adoption
of induction chemotherapy before EPP2 and
refinement of diagnostic techniques, such as
positron emission tomography and computed
tomography, more patients will be operated
on with the possibility of preserving their
native pericardium, thereby reducing the in-
cidence of cardiac complications, reducing
the operative time, and facilitating the an-
chorage of the diaphragmatic patch.
We would also like to mention that chy-
lothorax is another potential complication
of EPP, with a recent article reporting an
18.7% incidence.2 Although no postopera-
tive chylothorax has been reported in the
series by Sugarbaker et al,1 we would like
to re-emphasize the importance of prophy-
lactic thoracic duct ligation during right-
sided procedures.
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Reply to the Editor:
The primary goal of extrapleural pneumo-
nectomy in mesothelioma is to perform a
complete macroscopic cytoreduction. Rou-
tine pericardiectomy is an important step in
achieving this goal. The issue of pericardial
resection and reconstruction from the mor-
bidity standpoint is a higher atrial fibrilla-
tion rate, the risk of cardiac herniation from
a poorly constructed patch, tamponade
from a tight patch, and epicarditis.
Our high rate of atrial fibrillation com-
pared with that seen in other reports that
use similar resection of the pericardium
stems from our policy of monitoring all
patients with telemetry until discharge
from the hospital. Opening the pericardium
is only one of the multiple causes of atrial
fibrillation. Entry into the pericardium with
multiple random biopsies would also result
in a higher atrial fibrillation rate or at least
not a significant decrease in those rates.
Cardiac herniation or tamponade from a
poorly done pericardial reconstruction
would be avoided by not resecting the peri-
cardium. These are not common events,
however, and were more prevalent during
our earlier experience. However, from an
oncologic perspective, it would not be pru-
dent to risk a good cytoreduction, even in
the setting of a few negative random biopsy
specimens. It is this group of patients with
early disease that would benefit the most
from the most aggressive surgical interven-
tion.
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The operative time it takes to recon-
struct the pericardium is not significant,
and the diaphragmatic reconstruction is not
facilitated in our experience by leaving the
pericardium in.
Finally, we agree that personal experi-
ence with chylothorax should guide each
surgeon as to whether prophylactic thoracic
duct ligation should be used routinely.
Lambros Zellos, MD
David J. Sugarbaker, MD
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Brigham and Women’s Hospital
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Technique for microsphere injection
To the Editor:
We read with great interest the article by
Hedayati and associates1 recently pub-
lished in the Journal. The authors sug-
gested that axillary artery cannulation for
cardiopulmonary bypass is cerebroprotec-
tive from aortic atheroemboli by using ca-
nine models. We respectfully would like to
note some procedural inconsistencies that
might have lead to bias in the authors’
conclusions.
The authors assessed the distribution of
microspheres simulating aortic atheroem-
boli shed by patients during cardiopulmo-
nary bypass. However, the microsphere in-
jection method was inconsistent (eg, the
pump flow was not constant, and the rate of
microsphere injection was unclear), and the
reference blood withdrawal rate for calcu-
lating tissue blood flow was unclear. Be-
cause the distribution pattern of the micro-
spheres can be influenced easily by the
pump flow rate, microsphere injection rate,
shape of the aorta, and location of the in-
jection, more precise experimental proto-
cols might affect this study’s results.
One more point of concern in this study
is the size of the microspheres. Small mi-
crospheres (15 m in diameter) have been
used for measuring tissue blood flow,2 and
large microspheres (50 m in diameter)
have been used for creating microemboli3
by several investigators. Hedayati and
associates1 used microspheres 15 m in
diameter; however, they did not use the
microspheres to measure tissue blood flow
but rather as microemboli in this study.
Because atheroemboli are generally larger
than 15 m in diameter and because size
affects the degree of cerebral ischemia and
infarction,4 we believe that the larger mi-
crosphere should have been used to analyze
the risk of atheroemboli in the aorta during
cardiopulmonary bypass.
In light of these considerations, the au-
thors’ conclusion that “axillary artery can-
nulation for cardiopulmonary bypass is ce-
rebroprotective” cannot be fully supported
on the basis of the data presented. More
studies with larger microspheres or flow
characterization with both particle image
velocimetry and laser Doppler velocimetry
could provide more meaningful results and
insights on this subject to further under-
stand this clinically important topic.
Yoshio Ootaki, MD, PhD
Kiyotaka Fukamachi, MD, PhD
Department of Biomedical Engineering
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Reply to the Editor:
Thank you for your interest in our publica-
tion entitled “Axillary artery cannulation
for cardiopulmonary bypass reduces cere-
bral microemboli.” We are confident that
our conclusion, that axillary cannulation
reduces cerebral microemboli, is supported
by our experimental evidence. We apolo-
gize for any lack of clarity with our exper-
imental design. We agree that the distribu-
tion pattern of the microspheres might be
influenced by the pump flow rate, micro-
sphere injection rate, shape of the aorta,
location of the injection, and location of the
cardiopulmonary bypass cannulation site.
Using each animal as its own control en-
abled us to provide constant conditions for
each variable, with the only difference be-
ing the cannulation site.
Our microsphere injection method
was consistent for each animal. The only
variable was the cannulation site for car-
diopulmonary bypass. The pump flow
rate was constant during the 2 cannula-
tion techniques within each animal, al-
though the pump rate did vary from 1.9 to
3.4 L · min 1 · m 2 among animals to
maintain constant pressure among ani-
mals. Five million microspheres (2.5 
106 microspheres/mL) were injected over
1 minute.
Larger microspheres have been used to
induce infarction or ischemia and might
have been preferred if that was our inten-
tion. We were exclusively interested in the
distribution of the spheres and found no
evidence that the distribution of 50-m
spheres would have, in our model, altered
our impressive results. Atheroemboli range
in size, with the most numerous being the
smallest.1 We used 15-m spheres, as has
been done before in similar investigations.2
We agree with your suggestion that fur-
ther characterization of the flow pattern
through particle-imaging techniques will
provide additional evidence as to the supe-
rior ability of axillary cannulation to pro-
vide cerebroprotection, and we plan to do
so in the future to further corroborate the
vastly reduced stroke rate we have ob-
served when axillary perfusion was used in
our patients with high-risk aortas.
Steve J. Schomisch, BS
Alan H. Markowitz, MD
University Hospitals of Cleveland
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Carbodissection of the internal
thoracic artery
To the Editor:
I write with reference to the article by
Özkan and associates titled “A Carbon Di-
oxide Insufflation Technique for Prepara-
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